Cambridge, USA-based City Therapeutics has announced its launch with a vision to lead the future of RNA interference ...

Bayer (BAYN: DE) has partnered with MOMA Therapeutics to develop a small molecule oncology program using MOMA’s KNOMATIC ...

The UK has launched the Regulatory Innovation Office (RIO) to reduce regulatory barriers and fast-track approvals for new ...

Arda Therapeutics, a biotech focused on targeted cell depletion therapies for chronic diseases, has raised $43 million in a ...

US pharma major Bristol Myers Squibb’s recent approval from the US Food and Drug Administration (FDA) for Cobenfy (xanomeline ...

US biotech major Biogen revealed that felzartamab, an investigational anti-CD38 monoclonal antibody, has received ...

German pharma major Bayer has opened Bayer Co.Lab Shanghai, a new life science incubator in China’s Zhangjiang biopharma ...

Purespring Therapeutics, a UK-based gene therapy company focused on kidney disease, has raised £80 million ($105 million) in ...

German family-owned pharma major Boehringer Ingelheim and USA-based Circle Pharma (have entered into a research collaboration and license agreement with the shared goal to develop a first-in-class ...

Sage Therapeutics’ share price fell 11% to $6 in pre-market activity on Tuesday, after it announced disappointing top-line ...

Calluna Pharma, a biotech developing treatments for inflammatory and fibrotic diseases, has appointed Mark Gaffney as CEO.

GSK shared new Phase III data on Arexvy, its RSV vaccine, at the 2024 CHEST annual meeting. Results show a single dose of ...